Relenza (zanamivir) / GSK, Vaxart  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Relenza (zanamivir) / GSK, Vaxart
ACTRN12609000906257: An Unblinded Randomized Study of Influenza A/H1N1 2009 ("Swine flu")Resistance to Oseltamivir and Zanamivir

Recruiting
4
120
 
Prof Robert Booy, NHMRC
Influenza
 
 
2009-015100-25: Cohorte multicentrique nationale de patients atteints de grippe pandémique(nouveau virus A/H1N1v d’origine porcine)

Ongoing
4
1500
Europe
Tamiflu, Relenza 5mg/dose, mantadix 100mg, Rebetol, Rebetol 40mg/ml, Copegus 400 mg, Copegus 200 mg, Capsule*, Powder for nebuliser suspension, Oral solution, Tablet, Oseltamivir, Zanamivir 20mg (20 unidoses), Zanamivir 20mg (4 unidoses), Amantadine, Ribavirine 200mg (84 gélules), Ribavirine 200mg (112 gélules), Ribavirine 200mg (140 gélules), Ribavirine 200mg (168 gélules), Ribavirine, Ribavirine 400mg (14 comprimés), Ribavirine 400 mg (56 comprimés), Ribavirine 200 mg (28 comprimés), Ribavirine 200 mg (42 comprimés), Ribavirine 200mg (112 comprimés), Ribavirine 200mg (168 comprimés)
INSERM
Forme grave et forme bénigne de la Grippe A
 
 
ChiCTR-TNRC-10000938: A open-label, multicentre study to monitor the safety of inhaled zanamivir (as Rotadisk via Diskhaler device) in China.

Completed
4
400
 
Zanamivir
Beijing Chaoyang Hosital; GSK, GSK
Influenza
 
 

Download Options